Last reviewed · How we verify

NCT07312006: "CAT5-GS"

Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The "CAT5-GS" Study

Not yet recruiting NA Last updated 31 December 2025
What this trial tests

NA trial testing AirSeal Insufflation system in Pain, Postoperative in 74 participants. Not yet recruiting.

Timeline
30 January 2026
Primary endpoint
30 October 2026
1 January 2027

Quick facts

Lead sponsorSurgiQuest, Inc.
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment74
Start date30 January 2026
Primary completion30 October 2026
Estimated completion1 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

SurgiQuest, Inc.

Who can join

Adults 22 to 65, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study to compare two different insufflation devices during robotic laparoscopic sleeve gastrectomy surgery, AirSeal to DV5 insufflation, in Gastric Sleeve Procedures. Shoulder, neck and chest pain will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other SurgiQuest, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07312006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing